研究报告 |
|
|
|
|
Toll样受体4(TLR4)基因剔除小鼠构建及初步表型分析 |
郭洋1,3,万颖寒2,3,王珏2,3,龚慧2,3,周宇4,慈磊4,万志鹏4,孙瑞林4,费俭1,3,4,*,沈如凌2,3,*() |
1 同济大学生命科学与技术学院 上海 200092 2 上海实验动物研究中心 上海 201203 3 模式生物及比较医学联合实验室上海实验动物研究中心 同济大学生命科学与技术学院 上海 201203 4 上海市模式动物工程技术研究中心 上海 201318 |
|
Toll-like Receptor 4 (TLR4) Gene Knockout Mouse Model Construction and Preliminary Phenotypic Analysis |
GUO Yang1,3,WAN Ying-han2,3,WANG Jue2,3,GONG Hui2,3,ZHOU Yu4,CI Lei4,WAN Zhi-peng4,SUN Rui-lin4,FEI Jian1,3,4,*,SHEN Ru-ling2,3,*() |
1 School of Life Science and Technology, Tongji University, Shanghai 200092, China 2 Shanghai Laboratory Animal Research Center,Shanghai 201203, China 3 Joint Laboratory of Model Biology and Comparative Medical Research, Shanghai Laboratory Animal Research Center,Shanghai 201203,China 4 Shanghai Model Organisms Center Inc., Shanghai 201318, China |
引用本文:
郭洋,万颖寒,王珏,龚慧,周宇,慈磊,万志鹏,孙瑞林,费俭,沈如凌. Toll样受体4(TLR4)基因剔除小鼠构建及初步表型分析[J]. 中国生物工程杂志, 2020, 40(6): 1-9.
GUO Yang,WAN Ying-han,WANG Jue,GONG Hui,ZHOU Yu,CI Lei,WAN Zhi-peng,SUN Rui-lin,FEI Jian,SHEN Ru-ling. Toll-like Receptor 4 (TLR4) Gene Knockout Mouse Model Construction and Preliminary Phenotypic Analysis. China Biotechnology, 2020, 40(6): 1-9.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2001010
或
https://manu60.magtech.com.cn/biotech/CN/Y2020/V40/I6/1
|
[1] |
Medzhitov R, Janeway C A , Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell, 1997,91(3):295-298.
doi: 10.1016/s0092-8674(00)80412-2
pmid: 9363937
|
[2] |
Kawasaki T, Kawai T . Toll-like receptor signaling pathways. Front Immunol, 2014,5 461.
pmid: 25309543
|
[3] |
Kabelitz D . Expression and function of Toll-like receptors in T lymphocytes. Curr Opin Immunol, 2007,19(1):39-45.
pmid: 17129718
|
[4] |
Sepehri Z, Kiani Z, Kohan F , et al. Toll like receptor 4 and hepatocellular carcinoma; a systematic review. Life Sci, 2017,179 80-87.
pmid: 28472619
|
[5] |
Lu Y C, Yeh W C, Ohashi P S . LPS/TLR4 signal transduction pathway. Cytokine, 2008,42(2):145-151.
|
[6] |
Medzhitov R, Janeway C A , Jr. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol, 1997,9(1):4-9.
|
[7] |
Thomas A V, Broers A D, Vandegaart H F , et al. Genomic structure, promoter analysis and expression of the porcine (Sus scrofa) TLR4 gene. Molecular Immunology, 2006,43(6):653-659.
|
[8] |
Khedr L H, Nassar N N, Rashed L , et al. TLR4 signaling modulation of PGC1-alpha mediated mitochondrial biogenesis in the LPS-Chronic mild stress model: effect of fluoxetine and pentoxiyfylline. Life Sci, 2019,116869.
|
[9] |
Asea A . Heat shock proteins and toll-like receptors. Handb Exp Pharmacol, 2008, ( 183):111-127.
|
[10] |
Fei D, Meng X, Yu W , et al. Fibronectin (FN) cooperated with TLR2/TLR4 receptor to promote innate immune responses of macrophages via binding to integrin beta1. Virulence, 2018,9(1):1588-1600.
pmid: 30272511
|
[11] |
Voelcker V, Gebhardt C, Averbeck M , et al. Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4. Exp Dermatol, 2008,17(2):100-107.
pmid: 18031543
|
[12] |
Wang Y, Qian Y, Fang Q , et al. Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2. Nat Commun, 2017,8 13997.
doi: 10.1038/ncomms13997
pmid: 28045026
|
[13] |
Zhang M, Xue Y, Chen H , et al. Resveratrol inhibits MMP3 and MMP9 expression and secretion by suppressing TLR4/NF-kappaB/STAT3 activation in Ox-LDL-Treated HUVECs. Oxid Med Cell Longev, 2019,2019 9013169.
|
[14] |
Wang D, Gilbert J R, Taylor G M , et al. TLR4 inactivation in myeloid cells accelerates bone healing of a calvarial defect model in mice. Plast Reconstr Surg, 2017,140(2):296e-306e.
|
[15] |
Oblak A and Jerala R . Toll-like receptor 4 activation in cancer progression and therapy. Clin Dev Immunol, 2011,2011 609579.
pmid: 22110526
|
[16] |
Ohadian Moghadam S, Nowroozi M R . Toll-like receptors: the role in bladder cancer development, progression and immunotherapy. Scand J Immunol, 2019,e12818.
|
[17] |
Khademalhosseini M, Arababadi M K . Toll-like receptor 4 and breast cancer: an updated systematic review. Breast Cancer, 2019,26(3):265-271.
|
[18] |
Huang B, Zhao J, Li H , et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res, 2005,65(12):5009-5014.
|
[19] |
Kelly M G, Alvero A B, Chen R , et al. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res, 2006,66(7):3859-3868.
pmid: 16585214
|
[20] |
Hoshino K, Takeuchi O, Kawai T , et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol, 1999,162(7):3749-3752.
pmid: 10201887
|
[21] |
Wiedenheft B, Sternberg S H, Doudna J A . RNA-guided genetic silencing systems in bacteria and archaea. Nature, 2012,482(7385):331-338.
|
[22] |
Gasiunas G, Barrangou R, Horvath P , et al. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proceedings of the National Academy of Sciences of the United States of America, 2012,109(39):E2579-E2586.
|
[23] |
Wang H, Yang H, Shivalila C S , et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell, 2013,153(4):910-918.
|
[24] |
Shen B, Zhang J, Wu H , et al. Generation of gene-modified mice via Cas9/RNA-mediated gene targeting. Cell Research, 2013,23(5):720-723.
|
[25] |
Reyon D, Tsai S Q, Khayter C , et al. FLASH assembly of TALENs for high-throughput genome editing. Nature Biotechnology, 2012,30(5):460-465.
|
[26] |
Royet J . Infectious non-self recognition in invertebrates: lessons from Drosophila and other insect models. Mol Immunol, 2004,41(11):1063-1075.
|
[27] |
Takeuchi O, Akira S . Toll-like receptors; their physiological role and signal transduction system. Int Immunopharmacol, 2001,1(4):625-635.
pmid: 11357875
|
[28] |
Shi Y J, Gong H F, Zhao Q Q , et al. Critical role of toll-like receptor 4 (TLR4) in dextran sulfate sodium (DSS)-Induced intestinal injury and repair. Toxicol Lett, 2019,3157(23):23-30.
|
[29] |
Ruiz E, Penrose H M, Heller S , et al. Bacterial TLR4 and NOD2 signaling linked to reduced mitochondrial energy function in active inflammatory bowel disease. Gut Microbes, 2019, 1-14.
|
[30] |
Florim G M, Caldas H C, Gonçalves N N , et al. Activation of HMGB1 - TLR4 pathway and inflammasome contribute to enhanced inflammatory response in extended criteria and kidneys with KDPI ≥ 85. Transplantation, 2020,104(4):724-730.
|
[31] |
Zhang L, Sun D, Bao Y , et al. Nerolidol protects against LPS-induced acute kidney injury via inhibiting TLR4/NF-κB signaling. Phytotherapy Research: PTR, 2017,31(3):459-465.
|
[32] |
Zhao J, Zheng H, Sui Z , et al. Ursolic acid exhibits anti-inflammatory effects through blocking TLR4-MyD88 pathway mediated by autophagy. Cytokine, 2019,123:154-726.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|